Commonwealth Equity Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.48M | Buy |
|
|||||
|
2025
Q2 | $3.04M | Sell |
|
|||||
|
2025
Q1 | $2.55M | Buy |
|
|||||
|
2024
Q4 | $2.7M | Buy |
|
|||||
|
2024
Q3 | $3.12M | Buy |
|
|||||
|
2024
Q2 | $3.33M | Buy |
|
|||||
|
2024
Q1 | $3.68M | Buy |
|
|||||
|
2023
Q4 | $2.92M | Buy |
|
|||||
|
2023
Q3 | $1.82M | Sell |
|
|||||
|
2023
Q2 | $2.31M | Buy |
|
|||||
|
2023
Q1 | $1.82K | Sell |
|
|||||
|
2022
Q4 | $2.08M | Sell |
|
|||||
|
2022
Q3 | $7.01M | Buy |
|
|||||
|
2022
Q2 | $2.83M | Buy |
|
|||||
|
2022
Q1 | $2.71M | Buy |
|
|||||
|
2021
Q4 | $2.68M | Sell |
|
|||||
|
2021
Q3 | $4.3M | Buy |
|
|||||
|
2021
Q2 | $5.67M | Buy |
|
|||||
|
2021
Q1 | $3.67M | Buy |
|
|||||
|
2020
Q4 | $4.27M | Buy |
|
|||||
|
2020
Q3 | $2.07M | Sell |
|
|||||
|
2020
Q2 | $1.83M | Sell |
|
|||||
|
2020
Q1 | $1.87M | Buy |
|
|||||
|
2019
Q4 | $1.86M | Buy |
|
|||||
|
2019
Q3 | $746K | Buy |
|
|||||
|
2019
Q2 | $839K | Buy |
|
|||||
|
2019
Q1 | $601K | Buy |
|
|||||
|
2018
Q4 | $364K | Sell |
|
|||||
|
2018
Q3 | $590K | Buy |
|
|||||
|
2018
Q2 | $727K | Buy |
|
|||||
|
2018
Q1 | $263K | Buy |
|